Toxicogenomics - helping reshape drug discovery (?)
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Danielle Stretch.
Three years ago, the idea of toxicogenomics – using omic technologies
to understand/predict drug toxicity – started becoming a much
discussed goal in industries such as pharma. Within a year, business
was looking good for companies set up around what was still a very
academic endeavor. Over the last year, notable enterprises behind
toxicogenomics have largely failed. What has gone wrong? Is this
another omics bubble prematurely pushing new science?
Quin Wills (SimuGen Ltd), will give an introduction to current
toxicogenomic approaches, aimed at those interested in an overview of
the scientific/statistical challenges, drug discovery and current
technologies.
This talk is part of the Computational and Systems Biology series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|